Ask AI
ProCE Banner Series

Conference to Clinic: Emerging Next-Generation KRAS G12C-Targeted Therapies in NSCLC

Expert-led challenge-your-knowledge educational program with insights and best practices for the management of patients with KRAS G12C–mutated NSCLC, including emerging data and identifying patients for available clinical trials.

  AMA
Who Should Attend

This activity is intended for oncologists and other healthcare professionals who care for patients with non-small-cell lung cancer. 

All Events

Conference to Clinic: Emerging Next-Generation KRAS G12C-Targeted Therapies in NSCLC

Upcoming Events

June

25

2026

2:00 PM - 3:00 PM Eastern Time (ET)

Virtual

Topics

Lung Cancers

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners’ knowledge, competence, and performance in providing patient-centric, data-driven, culturally sensitive care for individuals with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma based on the latest clinical evidence and local expert recommendations.

Target Audience
This activity is intended for oncologists and other healthcare professionals who care for patients with non-small-cell lung cancer. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify patients with NSCLC who may be eligible for enrollment on clinical trials with next-generation KRAS G12C–targeted therapies

  • Evaluate how next-generation KRAS G12C–targeted agents in late-phase clinical trials might be integrated into real-world clinical practice for patients with NSCLC

  • Discuss with colleagues and patients ongoing advances in targeting KRAS G12C for solid tumors

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Lilly.

Lilly

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191